Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival analysis. [electronic resource]
Producer: 20201006Description: 209-213 p. digitalISSN:- 1095-6859
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab -- administration & dosage
- Carboplatin -- administration & dosage
- Carcinoma, Ovarian Epithelial -- drug therapy
- Chemotherapy, Adjuvant
- Cytoreduction Surgical Procedures -- methods
- Female
- Humans
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Staging
- Neoplasm, Residual
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- administration & dosage
- Prognosis
- Progression-Free Survival
- Retrospective Studies
- Survival Rate
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.